Interview with John Fagan, General Manager, Sanofi SA
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market place, and within Sanofi as an organization? The…
Address: 2 Bond Street, Grand Central Ext. 1, Midrand 1685,South Africa
Tel: +27 (0)11 256 3700
Web: http://www.sanofi-aventis.co.za/l/za/en/index.jsp
Sanofi is the leading multinational pharmaceutical company in South Africa and one of the world’s leading pharmaceutical companies serving the cause of improving health and wellbeing.
Present in more than 100 countries, with around 11 000 scientists, we have around
100 000 employees working to improve health and wellbeing.
Our Global headquarters are in Paris, France.
Sanofi-aventis focuses its activities on 7 major therapeutic areas:
Cardiovascular
Thrombosis
Oncology
Central Nervous System
Metabolic Disorders
Internal Medicine
Vaccines
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market place, and within Sanofi as an organization? The…
The CEO of Ascendis Health talks about their business model, being a long-term investment company that brings together healthy businesses in the healthcare industry, and how the diversification of their product…
Merck’s managing director for South Africa and general manager for Southeast Africa reveals why the company takes a long-term perspective when investing in African countries, helping to shape healthcare systems,…
The general manager of Novagen Pharma reveals how they are the second largest supplier of ARVs within the private South African market, how there is much room for the generics…
The country manager and Global Established Products Business Lead at Pfizer South Africa reveals how the private sector is committed to expanding healthcare for South Africans, why her ambition is…
The country manager of Dr. Reddy´s South Africa explains that while the perception of the quality of generics has improved in South Africa, there is still a long way to…
The CEO of NAPM reveals how the main challenge facing his members is the length of time needed to register a generic product, taking up to four years and acting…
Having spent two months as the head of Novartis South Africa, what is your first assignment as General Manager, could you share with our readers what were the surprises for…
Mr. Miller, you have been Vice President and Managing Director of Mylan’s operations in South Africa since 2008. What mission were you assigned back then, and in those three years,…
South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental…
Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an…
If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the…
Focus Reports is back in South Africa as part of a second set of reports on the BRICS. What would you say are the main changes in the market since…
See our Cookie Privacy Policy Here
